drugset / Trial / NCT00174811

Comparative Study to Evaluate the Efficacy and Safety of Telithromycin Given Once Daily Versus Cefuroxime Axetil Given Twice Daily in Children With Middle Ear Infections

NCT00174811

Phase 3 Terminated 639 enrolled Sanofi
RandomizedParallel-groupDouble-blindTreatment

Summary

The clinical activity of telithromycin vs. cefuroxime in children with acute infections of the middle ear, ages 6 months to 59 months old will be studied.

Timeline

Start
2005-06
Primary completion
2006-06
Completion
2006-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Telithromycin Small molecule 25 mg/kg

Indications